Maria Paraskevaidi
Overview
Explore the profile of Maria Paraskevaidi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
771
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kechagias K, Kalliala I, Bowden S, Athanasiou A, Paraskevaidi M, Paraskevaidis E, et al.
BMJ
. 2022 Aug;
378:e070135.
PMID: 35922074
Objective: To explore the efficacy of human papillomavirus (HPV) vaccination on the risk of HPV infection and recurrent diseases related to HPV infection in individuals undergoing local surgical treatment. Design:...
12.
Athanasiou A, Veroniki A, Efthimiou O, Kalliala I, Naci H, Bowden S, et al.
Lancet Oncol
. 2022 Jul;
23(8):1097-1108.
PMID: 35835138
Background: The trade-off between comparative effectiveness and reproductive morbidity of different treatment methods for cervical intraepithelial neoplasia (CIN) remains unclear. We aimed to determine the risks of treatment failure and...
13.
Zikopoulos A, Galani A, Siristatidis C, Georgiou I, Mastora E, Paraskevaidi M, et al.
J Clin Med
. 2022 Mar;
11(5).
PMID: 35268308
(1) Background: Nowadays, pregnancy can be achieved by in vitro fertilisation (IVF) or by intracytoplasmic sperm injection (ICSI) for many infertile couples. However, implantation failure still remains a significant problem...
14.
Giannos P, Kechagias K, Bowden S, Tabassum N, Paraskevaidi M, Kyrgiou M
Front Oncol
. 2021 Dec;
11:779042.
PMID: 34900731
The investigation of differentially expressed genes (DEGs) and their interactome could provide valuable insights for the development of markers to optimize cervical intraepithelial neoplasia (CIN) screening and treatment. This study...
15.
Mitra A, MacIntyre D, Paraskevaidi M, Moscicki A, Mahajan V, Smith A, et al.
Genome Med
. 2021 Nov;
13(1):176.
PMID: 34736529
Background: Vaginal microbiota (VMB) composition is altered in women with cervical intra-epithelial neoplasia (CIN) compared to healthy controls and is associated with disease progression. However, the impact of CIN excision...
16.
Kechagias K, Katsikas Triantafyllidis K, Kyriakidou M, Giannos P, Kalliala I, Veroniki A, et al.
Nutrients
. 2021 Oct;
13(10).
PMID: 34684458
While the contributing factors leading to endometriosis remain unclear, its clinical heterogeneity suggests a multifactorial causal background. Amongst others, caffeine has been studied extensively during the last decade as a...
17.
Bauer-Negrini G, Deckmann I, Schwingel G, Hirsch M, Fontes-Dutra M, Carello-Collar G, et al.
Behav Brain Res
. 2021 Oct;
418:113629.
PMID: 34656692
Mice homozygous for the nude mutation (Foxn1) are hairless and exhibit congenital dysgenesis of the thymic epithelium, resulting in a primary immunodeficiency of mature T-cells, and have been used for...
18.
Paraskevaidis E, Athanasiou A, Kalliala I, Batistatou A, Paraskevaidi M, Bilirakis E, et al.
Eur J Obstet Gynecol Reprod Biol
. 2021 Jul;
264:56-59.
PMID: 34273753
Purpose: The aim of this study is to present a single department's experience on cervical cancer cases following previous excision of cervical intraepithelial neoplasia (CIN) and to discuss potential pathogenesis....
19.
Luo Y, Liu H, Wu C, Paraskevaidi M, Deng Y, Shi W, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2021 Apr;
255:119694.
PMID: 33799187
The present study aimed to investigate whether attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy coupled with multivariate analysis could be applied to discriminate and classify among breast tumour molecular subtypes...
20.
Paraskevaidi M, Cameron S, Whelan E, Bowden S, Tzafetas M, Mitra A, et al.
EBioMedicine
. 2020 Sep;
60:103017.
PMID: 32980699
Background: The introduction of high-risk human papillomavirus (hrHPV) testing as part of primary cervical screening is anticipated to improve sensitivity, but also the number of women who will screen positive....